GR3032643T3 - Phenoxyphenylacetic acid derivatives. - Google Patents
Phenoxyphenylacetic acid derivatives.Info
- Publication number
- GR3032643T3 GR3032643T3 GR20000400340T GR20000400340T GR3032643T3 GR 3032643 T3 GR3032643 T3 GR 3032643T3 GR 20000400340 T GR20000400340 T GR 20000400340T GR 20000400340 T GR20000400340 T GR 20000400340T GR 3032643 T3 GR3032643 T3 GR 3032643T3
- Authority
- GR
- Greece
- Prior art keywords
- acid derivatives
- phenoxyphenylacetic acid
- phenoxyphenylacetic
- derivatives
- vasospasm
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
- C07C59/70—Ethers of hydroxy-acetic acid, e.g. substitutes on the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/64—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3445593A | 1993-03-19 | 1993-03-19 | |
US19746794A | 1994-02-24 | 1994-02-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3032643T3 true GR3032643T3 (en) | 2000-06-30 |
Family
ID=26710968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20000400340T GR3032643T3 (en) | 1993-03-19 | 2000-02-11 | Phenoxyphenylacetic acid derivatives. |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0617001B1 (el) |
JP (1) | JPH08508034A (el) |
KR (1) | KR960700992A (el) |
CN (1) | CN1119434A (el) |
AT (1) | ATE189217T1 (el) |
AU (1) | AU679710B2 (el) |
CA (1) | CA2119051A1 (el) |
CZ (1) | CZ233595A3 (el) |
DE (1) | DE69422742T2 (el) |
DK (1) | DK0617001T3 (el) |
ES (1) | ES2141197T3 (el) |
FI (1) | FI954404A (el) |
GR (1) | GR3032643T3 (el) |
HR (1) | HRP940179B1 (el) |
HU (1) | HU217028B (el) |
IL (1) | IL108944A0 (el) |
NO (1) | NO953672L (el) |
NZ (1) | NZ263414A (el) |
PL (1) | PL175786B1 (el) |
PT (1) | PT617001E (el) |
RU (1) | RU2139273C1 (el) |
SK (1) | SK114795A3 (el) |
WO (1) | WO1994021590A1 (el) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6124343A (en) * | 1919-01-27 | 2000-09-26 | Rhone-Poulenc Rorer Limited | Substituted phenyl compounds with a substituent having a thienyl ring |
US5514696A (en) * | 1992-05-06 | 1996-05-07 | Bristol-Myers Squibb Co. | Phenyl sulfonamide endothelin antagonists |
US5686478A (en) * | 1993-07-20 | 1997-11-11 | Merck & Co. Inc. | Endothelin antagonists |
EP0774965A4 (en) * | 1994-08-08 | 1997-10-29 | Merck & Co Inc | PHENOXYPHENYLACETIC ACID DERIVATIVES |
US5612359A (en) * | 1994-08-26 | 1997-03-18 | Bristol-Myers Squibb Company | Substituted biphenyl isoxazole sulfonamides |
US5538991A (en) * | 1994-09-14 | 1996-07-23 | Merck & Co., Inc. | Endothelin antagonists bearing 5-membered heterocyclic amides |
US5559135A (en) * | 1994-09-14 | 1996-09-24 | Merck & Co., Inc. | Endothelin antagonists bearing pyridyl amides |
NZ298853A (en) * | 1995-01-27 | 1998-07-28 | Rhone Poulenc Rorer Ltd | 5-[2-cyano-phenoxy]-2-phenyl-acetic acid derivatives |
US5780473A (en) * | 1995-02-06 | 1998-07-14 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
US5760038A (en) * | 1995-02-06 | 1998-06-02 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
DE19527568A1 (de) | 1995-07-28 | 1997-01-30 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
US5846990A (en) * | 1995-07-24 | 1998-12-08 | Bristol-Myers Squibb Co. | Substituted biphenyl isoxazole sulfonamides |
DE19528418A1 (de) * | 1995-08-02 | 1997-02-06 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
DE19530032A1 (de) * | 1995-08-16 | 1997-02-20 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
DE19537548A1 (de) * | 1995-10-09 | 1997-04-10 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
JPH09124620A (ja) * | 1995-10-11 | 1997-05-13 | Bristol Myers Squibb Co | 置換ビフェニルスルホンアミドエンドセリン拮抗剤 |
AU703486B2 (en) * | 1995-12-12 | 1999-03-25 | Merck & Co., Inc. | Process for the preparation of an endothelin antagonist |
US5688974A (en) * | 1995-12-12 | 1997-11-18 | Merck & Co., Inc. | Process for the preparation of an endothelin antagonist |
US5977117A (en) * | 1996-01-05 | 1999-11-02 | Texas Biotechnology Corporation | Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin |
US6090836A (en) * | 1996-02-02 | 2000-07-18 | Merck & Co., Inc. | Benzisoxazole-derived antidiabetic compounds |
US5847008A (en) * | 1996-02-02 | 1998-12-08 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
US6020382A (en) * | 1996-02-02 | 2000-02-01 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
ATE293963T1 (de) * | 1996-02-02 | 2005-05-15 | Merck & Co Inc | Verfahren zur behandlung von diabetes und verwandter krankheitszustände. |
US5859051A (en) * | 1996-02-02 | 1999-01-12 | Merck & Co., Inc. | Antidiabetic agents |
US5856507A (en) * | 1997-01-21 | 1999-01-05 | Bristol-Myers Squibb Co. | Methods for the preparation of biphenyl isoxazole sulfonamides |
CZ263098A3 (cs) | 1996-02-20 | 1999-05-12 | Bristol-Myers Squibb Company | Způsoby přípravy bifenylisoxazolsulfonamidů |
US5939446A (en) * | 1996-04-09 | 1999-08-17 | Bristol-Myers Squibb Co. | Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists |
GB9609641D0 (en) * | 1996-05-09 | 1996-07-10 | Pfizer Ltd | Compounds useful in therapy |
DE19653024A1 (de) * | 1996-12-19 | 1998-06-25 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
US6160000A (en) * | 1996-12-23 | 2000-12-12 | Merck & Co., Inc. | Antidiabetic agents based on aryl and heteroarylacetic acids |
US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
TW536540B (en) * | 1997-01-30 | 2003-06-11 | Bristol Myers Squibb Co | Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe |
AU6187898A (en) * | 1997-01-30 | 1998-08-25 | Bristol-Myers Squibb Company | Method for preventing or treating low renin hypertension by administering an endothelin antagonist |
DE19710831A1 (de) * | 1997-03-15 | 1998-09-17 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
JP4917707B2 (ja) | 1997-09-26 | 2012-04-18 | アボット ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | エンドセリン拮抗剤およびレニン−アンギオテンシン系阻害剤から成る組合せ剤 |
DE19743143A1 (de) | 1997-09-30 | 1999-04-01 | Knoll Ag | Pharmazeutische Kombinationspräparate |
GB9722287D0 (en) * | 1997-10-22 | 1997-12-17 | Pfizer Ltd | Compounds useful in therapy |
DE19747788A1 (de) | 1997-10-29 | 1999-05-06 | Basf Ag | Substituierte 2-(2'-Pyridyloxy)phenylessigsäureamide, ihre Herstellung und Verwendung, sowie sie enthaltende Mittel |
US6410554B1 (en) | 1998-03-23 | 2002-06-25 | Merck & Co., Inc. | Combination therapy for the treatment of benign prostatic hyperplasia |
AU3011299A (en) * | 1998-03-23 | 1999-10-18 | Merck & Co., Inc. | Combination therapy for the treatment of benign prostatic hyperplasia |
KR100388506B1 (ko) * | 1998-03-31 | 2003-06-25 | 다나베 세이야꾸 가부시키가이샤 | 배뇨장애의 예방·치료제 |
US6017918A (en) * | 1998-08-06 | 2000-01-25 | Warner-Lambert Company | Phenyl glycine compounds and methods of treating atherosclerosis and restenosis |
US6284795B1 (en) * | 1998-09-04 | 2001-09-04 | Warner-Lambert Company | Sulfonamide compounds and methods of treating atherosclerosis and restenosis |
JP2002540088A (ja) | 1999-03-19 | 2002-11-26 | ブリストル−マイヤーズ スクイブ カンパニー | ビフェニルイソキサゾール・スルホンアミド化合物の製造法 |
AU1073001A (en) * | 1999-10-12 | 2001-04-23 | Basf Aktiengesellschaft | Method of identifying inhibitors of cdc25 |
ATE502928T1 (de) | 2000-11-01 | 2011-04-15 | Millennium Pharm Inc | Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung |
JP2004521124A (ja) | 2001-02-09 | 2004-07-15 | メルク エンド カムパニー インコーポレーテッド | 糖尿病および脂質障害用の2−アリールオキシ−2−アリールアルカン酸類 |
KR20050008661A (ko) * | 2002-03-20 | 2005-01-21 | 메타볼렉스, 인코포레이티드 | 치환된 페닐아세트산 |
US8614236B2 (en) | 2006-12-12 | 2013-12-24 | University Of Washington | Methods of treating pulmonary disease using acetazolamide and structurally related derivatives |
CN101042381B (zh) * | 2007-04-28 | 2014-01-08 | 长春迈灵生物工程有限公司 | 一种地舍平的检测方法 |
WO2011056126A1 (en) * | 2009-11-09 | 2011-05-12 | Novadex Pharmaceuticals Ab | Novel 1,3-oxazolidine compounds and their use as renin inhibitors |
JP5830534B2 (ja) | 2010-07-09 | 2015-12-09 | ファイザー・リミテッドPfizer Limited | 化合物 |
ES2532357T3 (es) | 2010-07-12 | 2015-03-26 | Pfizer Limited | Derivados de sulfonamida como inhibidores de Nav1.7 para el tratamiento del dolor |
US8772343B2 (en) | 2010-07-12 | 2014-07-08 | Pfizer Limited | Chemical compounds |
EP2593432B1 (en) | 2010-07-12 | 2014-10-22 | Pfizer Limited | N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors |
EP2593431B1 (en) | 2010-07-12 | 2014-11-19 | Pfizer Limited | N-sulfonylbenzamides as inhibitors of voltage-gated sodium channels |
CA2804716A1 (en) | 2010-07-12 | 2012-01-19 | Pfizer Limited | Chemical compounds |
SG191040A1 (en) | 2010-12-23 | 2013-08-30 | Pfizer | Glucagon receptor modulators |
WO2012107850A1 (en) | 2011-02-08 | 2012-08-16 | Pfizer Inc. | Glucagon receptor modulator |
EP2734503B1 (en) | 2011-07-22 | 2015-09-16 | Pfizer Inc. | Quinolinyl glucagon receptor modulators |
EP2791108B1 (en) | 2011-12-15 | 2016-07-27 | Pfizer Limited | Sulfonamide derivatives |
CN111825564B (zh) * | 2020-09-21 | 2020-12-29 | 西藏甘露藏药股份有限公司 | 一种从渣驯中提取的化合物、制备方法及其用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1408738A (fr) * | 1964-04-29 | 1965-08-20 | Nobel Bozel | Nouveaux dérivés de l'acide bis(hydroxy-4-phényl)-acétique |
US4748272A (en) * | 1986-08-01 | 1988-05-31 | Rorer Pharmaceutical Corp. | Phenoxyphenylacetates for use as potential modulators of arichidonic acid pathways |
JPS63122605A (ja) * | 1986-11-10 | 1988-05-26 | Tokuyama Soda Co Ltd | 除草剤組成物 |
-
1994
- 1994-03-10 AT AT94301728T patent/ATE189217T1/de not_active IP Right Cessation
- 1994-03-10 DK DK94301728T patent/DK0617001T3/da active
- 1994-03-10 ES ES94301728T patent/ES2141197T3/es not_active Expired - Lifetime
- 1994-03-10 EP EP94301728A patent/EP0617001B1/en not_active Expired - Lifetime
- 1994-03-10 DE DE69422742T patent/DE69422742T2/de not_active Expired - Fee Related
- 1994-03-10 PT PT94301728T patent/PT617001E/pt unknown
- 1994-03-11 IL IL10894494A patent/IL108944A0/xx unknown
- 1994-03-15 CA CA002119051A patent/CA2119051A1/en not_active Abandoned
- 1994-03-17 SK SK1147-95A patent/SK114795A3/sk unknown
- 1994-03-17 PL PL94310661A patent/PL175786B1/pl unknown
- 1994-03-17 NZ NZ263414A patent/NZ263414A/en unknown
- 1994-03-17 WO PCT/US1994/002871 patent/WO1994021590A1/en not_active Application Discontinuation
- 1994-03-17 RU RU95121625A patent/RU2139273C1/ru active
- 1994-03-17 CZ CZ952335A patent/CZ233595A3/cs unknown
- 1994-03-17 CN CN94191512A patent/CN1119434A/zh active Pending
- 1994-03-17 HU HU9502725A patent/HU217028B/hu not_active IP Right Cessation
- 1994-03-17 JP JP6521226A patent/JPH08508034A/ja not_active Withdrawn
- 1994-03-18 HR HR940179A patent/HRP940179B1/xx not_active IP Right Cessation
- 1994-03-18 AU AU57878/94A patent/AU679710B2/en not_active Ceased
-
1995
- 1995-09-18 NO NO953672A patent/NO953672L/no not_active Application Discontinuation
- 1995-09-18 KR KR1019950704018A patent/KR960700992A/ko not_active Application Discontinuation
- 1995-09-18 FI FI954404A patent/FI954404A/fi unknown
-
2000
- 2000-02-11 GR GR20000400340T patent/GR3032643T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PL310661A1 (en) | 1995-12-27 |
JPH08508034A (ja) | 1996-08-27 |
WO1994021590A1 (en) | 1994-09-29 |
CA2119051A1 (en) | 1994-09-20 |
AU5787894A (en) | 1994-09-22 |
IL108944A0 (en) | 1994-06-24 |
FI954404A0 (fi) | 1995-09-18 |
ATE189217T1 (de) | 2000-02-15 |
EP0617001A1 (en) | 1994-09-28 |
NO953672D0 (no) | 1995-09-18 |
EP0617001B1 (en) | 2000-01-26 |
DE69422742T2 (de) | 2000-08-17 |
DE69422742D1 (de) | 2000-03-02 |
AU679710B2 (en) | 1997-07-10 |
KR960700992A (ko) | 1996-02-24 |
NZ263414A (en) | 1997-09-22 |
HU217028B (hu) | 1999-11-29 |
PL175786B1 (pl) | 1999-02-26 |
HUT73658A (en) | 1996-09-30 |
CN1119434A (zh) | 1996-03-27 |
RU2139273C1 (ru) | 1999-10-10 |
DK0617001T3 (da) | 2000-04-17 |
CZ233595A3 (en) | 1996-01-17 |
ES2141197T3 (es) | 2000-03-16 |
FI954404A (fi) | 1995-09-18 |
HRP940179A2 (en) | 1998-02-28 |
HRP940179B1 (en) | 2000-10-31 |
NO953672L (no) | 1995-11-17 |
HU9502725D0 (en) | 1995-11-28 |
SK114795A3 (en) | 1996-06-05 |
PT617001E (pt) | 2000-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9502725D0 (en) | Phenoxyphenylacetic acid derivatives | |
NO986090L (no) | Fenylalaninderivater som integrininhibitorer | |
AP9701004A0 (en) | Low molecular weight bicyclic thrombin inhibitors. | |
CA2382406A1 (en) | Substituted 2-arylbenzazole compounds and their use as antitumour agents | |
CA2201785A1 (en) | New carboxylic acid derivatives, their preparation and their use | |
CA2133439A1 (en) | Compounds useful for treating allergic and inflammatory diseases | |
CA2325933A1 (en) | Fatty acid derivatives of bile acids and bile acid derivatives | |
WO2000071516A3 (en) | INHIBITORS OF FACTOR Xa | |
ATE195948T1 (de) | Endothelinantagonisten | |
NZ337589A (en) | [1,4]diazepino[6,7,1-hi]indol-4-ones and there use in treating inflammatory diseases | |
DE69528711D1 (de) | Chinazolinen als inhibitoren des endothelin konvertierenden enzyme | |
PL326236A1 (en) | Novel compounds - derivatives of sulphonylpyrimidine exhibiting anticarcinogenous effect and method of obtaining them | |
CA2014062A1 (en) | Pyridine derivatives | |
HK1111683A1 (en) | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors | |
CA2128876A1 (en) | Triazolopyrimidine derivatives as angiotensin ii receptor antagonists | |
CA2185394A1 (en) | Biotinderivate | |
GR3002829T3 (en) | 4-nitrogen substituted isoquinolinol compounds having cardiotonic, phosphodiesterase fraction iii inhibiting properties and/or renal vasodilating properties | |
KR100344711B1 (el) | ||
MX9704594A (es) | Peptidos heterociclicos de la ceto-arginina, como inhibidores de la trombina. | |
TH15241B (el) | ||
TH17364A (el) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ML | Lapse due to non-payment of fees |